Xiaohua Hu

Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial

Feng Wang, Ying Jin, Min Wang et al. · Nature Medicine · 2024 · 165 citations

Medicine, Oncology, Pharmacology +14

The misdiagnosis of prolonged disorders of consciousness by a clinical consensus compared with repeated coma-recovery scale-revised assessment

Jing Wang, Xiaohua Hu, Zhouyao Hu et al. · BMC Neurology · 2020 · 142 citations · Full text

Medicine, Internal Medicine, Diagnostic Reasoning +9

Reliability and validity of the Chinese version of the Childhood Trauma Questionnaire-Short Form for inpatients with schizophrenia

Wenjuan Jiang, Bao‐Liang Zhong, Lianzhong Liu et al. · PLoS ONE · 2018 · 119 citations · Full text

Medicine, Psychiatry, Psychology +14

Clinical roles of the aberrantly expressed lncRNAs in lung squamous cell carcinoma: a study based on RNA-sequencing and microarray data mining

Wenjie Chen, Ruixue Tang, Rong‐Quan He et al. · Oncotarget · 2017 · 90 citations · Full text

Medicine, Molecular Biology, Oncology +13

Perioperative toripalimab + platinum-doublet chemotherapy vs chemotherapy in resectable stage II/III non-small cell lung cancer (NSCLC): Interim event-free survival (EFS) analysis of the phase III Neotorch study.

Shun Lü, Lin Wu, Wei Zhang et al. · Journal of Clinical Oncology · 2023 · 88 citations

Medicine, Perioperative Medicine, Pharmacology +13